Compare VTRS & HII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTRS | HII |
|---|---|---|
| Founded | 1961 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Marine Transportation |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 12.0B |
| IPO Year | N/A | N/A |
| Metric | VTRS | HII |
|---|---|---|
| Price | $10.96 | $304.10 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 5 |
| Target Price | $11.17 | ★ $320.60 |
| AVG Volume (30 Days) | ★ 7.9M | 417.3K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | ★ 4.39% | 1.81% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 14.50 |
| Revenue | ★ $14,124,400,000.00 | $12,012,000,000.00 |
| Revenue This Year | N/A | $5.67 |
| Revenue Next Year | $1.16 | $5.24 |
| P/E Ratio | ★ N/A | $21.01 |
| Revenue Growth | N/A | ★ 2.60 |
| 52 Week Low | $6.85 | $158.88 |
| 52 Week High | $13.13 | $330.00 |
| Indicator | VTRS | HII |
|---|---|---|
| Relative Strength Index (RSI) | 60.39 | 47.44 |
| Support Level | $10.67 | $304.01 |
| Resistance Level | $10.93 | $318.61 |
| Average True Range (ATR) | 0.24 | 8.71 |
| MACD | 0.01 | -1.24 |
| Stochastic Oscillator | 90.23 | 35.46 |
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships including amphibious landing ships and Arleigh Burke-class destroyers, while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines. HII shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's mission technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.